Q fever vaccine shortage leaves rural workers facing an uncertain summer
Manufacturing problems are expected to interrupt supplies of an important vaccine used by people exposed to livestock, with new batches anticipated late in December.
Australia is expected to run out of available Q fever vaccine supplies this week, according to manufacturer CSL Seqirus. The company says difficulties with raw materials and equipment have interrupted production, and it expects two expedited batches to become available late in December. The timing remains an estimate rather than a guarantee of immediate availability to every clinic.
Q fever is a bacterial infection associated with exposure to animals and contaminated material. It can cause severe flu-like illness and, in some cases, long-term complications. Workers on farms, in shearing sheds and in meat processing can face particular exposure risks.
ABC Rural reported 991 cases recorded in Australia last year, the highest annual number since national monitoring began in 1991. The figures underline why vaccine availability is more than a routine procurement problem for agricultural businesses. Some employers say they have struggled to secure doses for staff for months.
The manufacturer apologised for the disruption and described the product as technically complex, with a lengthy production process. Health authorities said CSL Seqirus manages manufacturing, allocation and distribution under the relevant supply arrangements.
People who work with livestock should seek current medical and workplace-health advice about their own exposure and vaccine eligibility. A dated news report cannot confirm stock levels at a particular clinic or replace clinical guidance.
Source & reporting note
ABC Rural — Australia faces Q fever vaccine shortage, 12 November 2026 ↗Prepared for the Friday, 13 November 2026 edition using the reporting linked above. This is an archived account of what was known at publication.